Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cardiac Failure|November 22, 2023
Stabilization of Rapidly Progressive Cardiac Allograft Vasculopathy Using mTOR Inhibition After Heart TransplantationBrett W Sperry, Rayan El Zein, Timothy J Fendler, et al.JACC. Heart Failure|December 3, 2021
Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth ModelYasser Sammour, John A Spertus, Bethany A Austin, et al.Journal of the American College of Cardiology|March 21, 2020
Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT TrialSuzanne V Arnold, Gregg W Stone, Michael J Mack, et al.Clinical Transplantation|February 19, 2021
Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patientsKeerthi T Gondi, Andrew Kao, Jodie Linard, et al.Journal of Cardiac Failure|March 23, 2021
PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic CorrelatesYasser Sammour, Christopher Dezorzi, Bethany A Austin, et al.Journal of Cardiac Failure|December 28, 2020
Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound AnalysisBrett W Sperry, Raed Qarajeh, Mohamed A Omer, et al.Circulation. Heart Failure|May 19, 2023
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF TrialsMichael E Nassif, Sheryl L Windsor, Kensey Gosch, et al.JACC. Advances|June 27, 2025
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HFAndrew J Sauer, Joycie Chang, Zhuxuan Fu, et al.Pageof 2